| Financial Year |
March 31 2023 |
| Monetary Funds |
770,036,732.23 |
| Held-for-trading Financial Assets |
47,900,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
193,256,299.25 |
| Advances to Suppliers |
30,629,157.09 |
| Other Receivables |
5,837,205.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
163,246,149.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
524,171.50 |
| Total Current Assets |
1,261,101,273.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
483,141,804.26 |
| Investment Properties |
-- |
| Fixed Assetes |
141,432,439.53 |
| Under-construction Projects |
22,313,711.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,389,404.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
8,401,203.16 |
| Other Non-Current Assets |
1,365,643.40 |
| Sub-Total of Non-Current Assets |
755,744,359.23 |
| Total Assets |
2,016,845,632.61 |
| Short-Term Loans |
71,843,791.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,067,469.85 |
| Accounts Payable |
107,490,580.35 |
| Accounts Received In Advance |
12,200,000.00 |
| Employee Compensation Payable |
6,223,991.13 |
| Taxes Payable |
1,249,564.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,408,007.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
497,805.11 |
| Other Current Liabilities |
399,218.27 |
| Sub-Total of Current Liabilities |
244,741,972.59 |
| Long-term Loans |
41,504,775.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,869,359.40 |
| Total Liabilities |
291,611,331.99 |
| Paid-In Capital(Or Share Stock) |
467,625,470.00 |
| Capital Surplus |
269,979,002.64 |
| Surplus Reserve |
88,837,970.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
716,375,442.39 |
| Minority Stockholder's Interest |
182,416,415.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,542,817,885.38 |
| Owner's Equity（Stockholder's Equity） |
1,725,234,300.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,016,845,632.61 |
